======= MKNK2 =======
== Gene Information ==
* **Official Symbol**: MKNK2
* **Official Name**: MAPK interacting serine/threonine kinase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2872|2872]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9HBH9|Q9HBH9]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=MKNK2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20MKNK2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/605069|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the calcium/calmodulin-dependent protein kinases (CAMK) Ser/Thr protein kinase family, which belongs to the protein kinase superfamily. This protein contains conserved DLG (asp-leu-gly) and ENIL (glu-asn-ile-leu) motifs, and an N-terminal polybasic region which binds importin A and the translation factor scaffold protein eukaryotic initiation factor 4G (eIF4G). This protein is one of the downstream kinases activated by mitogen-activated protein (MAP) kinases. It phosphorylates the eukaryotic initiation factor 4E (eIF4E), thus playing important roles in the initiation of mRNA translation, oncogenic transformation and malignant cell proliferation. In addition to eIF4E, this protein also interacts with von Hippel-Lindau tumor suppressor (VHL), ring-box 1 (Rbx1) and Cullin2 (Cul2), which are all components of the CBC(VHL) ubiquitin ligase E3 complex. Multiple alternatively spliced transcript variants have been found, but the full-length nature and biological activity of only two variants are determined. These two variants encode distinct isoforms which differ in activity and regulation, and in subcellular localization. [provided by RefSeq, Aug 2011].
* **UniProt Summary**: N/A
|Pkinase Tyr|
|Pkinase|
|Kdo|
|calcium-dependent protein serine/threonine kinase activity|
|cellular response to arsenic-containing substance|
|calmodulin-dependent protein kinase activity|
|extrinsic apoptotic signaling pathway in absence of ligand|
|signal transduction in absence of ligand|
|response to arsenic-containing substance|
|extrinsic apoptotic signaling pathway|
|PML body|
|peptidyl-serine phosphorylation|
|protein autophosphorylation|
|peptidyl-serine modification|
|calmodulin binding|
|nuclear body|
|apoptotic signaling pathway|
|regulation of translation|
|protein serine/threonine kinase activity|
|regulation of cellular amide metabolic process|
|posttranscriptional regulation of gene expression|
|hemopoiesis|
|hematopoietic or lymphoid organ development|
|immune system development|
|peptidyl-amino acid modification|
|apoptotic process|
|protein phosphorylation|
|programmed cell death|
|cell death|
|phosphorylation|
|ATP binding|
|intracellular signal transduction|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp308|Rapamycin 2μM plus FK-506 5μM R07 exp308]]|2.02|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8610
* **Expression level (log2 read counts)**: 6.55
{{:chemogenomics:nalm6 dist.png?nolink |}}